Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Elabbass Abdelmahmuod"'
Publikováno v:
Clinical Case Reports, Vol 9, Iss 3, Pp 1202-1206 (2021)
Abstract Severe COVID‐19 infection is associated with significant stress and marked immune response that can affect many organs and precipitate DKA, pancreatitis, and acute renal injury, which might be permanent.
Externí odkaz:
https://doaj.org/article/7da6b0944ceb40ecb83653e1c2c7251a
Publikováno v:
Clinical Case Reports, Vol 10, Iss 4, Pp n/a-n/a (2022)
Abstract Platelets are acute‐phase reactants, which can be elevated due to a secondary cause or less commonly because of a primary mechanism. Primary disorders include hematological conditions such as myelodysplastic syndrome, acute myeloid leukemi
Externí odkaz:
https://doaj.org/article/37786c7aa75b415087197b2570704936
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S39- (2021)
Objective: The aim of this review is to assess patients with chronic myeloid leukemia with concomitant JA2 positive for - their characteristics - response to treatment Methodology: We searched the English literature (Google Scholar, PubMed, and SCOPU
Externí odkaz:
https://doaj.org/article/ee058b48de604e90ad6e353bb971957d
Autor:
Mohammed Abdulgayoom, Mhd Kutaiba Albuni, Elabbass Abdelmahmuod, Khaled Murshed, Yassir Eldeeb
Publikováno v:
Clinical Case Reports, Vol 9, Iss 10, Pp n/a-n/a (2021)
Abstract The association between the COVID vaccine and MCD is temporal and by exclusion, and it is not fully established, but it should be considered in postvvaccine MCD.
Externí odkaz:
https://doaj.org/article/273818cb5a9642beb3a4a87b70229aed
Autor:
Mohammed A. Alamin, Mohammed Abdulgayoom, Sushil Niraula, Elabbass Abdelmahmuod, Ashraf O. Ahmed, Mohammed I. Danjuma
Publikováno v:
IDCases, Vol 26, Iss , Pp e01293- (2021)
Mucormycosis has multiple clinical phenotypes, which are more common in immunocompromised patients, especially those with diabetes mellitus. Debilitating rhino-orbital-cerebral and pulmonary infections by far represent the most typical clinical pheno
Externí odkaz:
https://doaj.org/article/b9cba6cf6d564bd88d555f99f63ad9f2
Autor:
Abdalla Fadul, ELMustafa Abdalla, Elabbass Abdelmahmuod, Mohammed Abdulgayoom, Elrazi Ali, Akram Al-warqi, Hani Al-yahary
Publikováno v:
Cureus.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c593c69219f35922cd6490bac6033d51
https://doi.org/10.7759/cureus.26436
https://doi.org/10.7759/cureus.26436
Publikováno v:
Cureus
Pulmonary tuberculosis is a common endemic disease in developing countries but its thrombogenic tendency is not well-studied and established yet. Pulmonary embolism is rarely reported in Mycobacterium tuberculosis infection. There are reports stating
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f391cba70eeec0295ecbbe124a63e832
http://europepmc.org/articles/PMC8315083
http://europepmc.org/articles/PMC8315083
Publikováno v:
Cureus
Idiopathic thrombocytopenic purpura (ITP) is an immune disorder in which antibodies attack platelets, leading to platelet destruction and increased bleeding risk. Standard treatment is to maintain a platelet count sufficient to mitigate the bleeding
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed5d3748ce2171d00bdf665e31d354b2
http://europepmc.org/articles/PMC8080309
http://europepmc.org/articles/PMC8080309
Eltrombopag is relatively new drug used in Thrombocytopenia. Its dose should be adjusted based on platelets count. It should be stopped when platelets count reach 400,000/mm³. Here, we share our case report of stopping Eltrombopag based on platelets
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cae065766f2999c8a6466cda98e1afce
https://doi.org/10.22541/au.160438331.13299327/v1
https://doi.org/10.22541/au.160438331.13299327/v1
Publikováno v:
The American Journal of Case Reports
Patient: Male, 49-year-old Final Diagnosis: Chronic lymphocytic leukemia • COVID-19 Symptoms: Feve • shortness of breath Medication: — Clinical Procedure: — Specialty: Hematology • Infectious Diseases Objective: Unusual clinical course Back
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d202bf071cb90999a5b68c99bf462924
https://doi.org/10.12659/ajcr.926062
https://doi.org/10.12659/ajcr.926062